The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Karin Wåhlander

AstraZeneca Research and Development Mölndal




Name/email consistency: high



  • AstraZeneca Research and Development Mölndal, Mölndal, Sweden. 2006
  • Experimental Medicine, AstraZeneca R&D, Mölndal, Sweden. 2003
  • Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Göteborg, Sweden. 2002


  1. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism. Wåhlander, K., Eriksson, H., Lundström, T., Billing Clason, S., Wall, U., Nyström, P., Wessman, P., Schulman, S. Br. J. Haematol. (2006) [Pubmed]
  2. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model. Wåhlander, K., Eriksson-Lepkowska, M., Nyström, P., Eriksson, U.G., Sarich, T.C., Badimon, J.J., Kalies, I., Elg, M., Bylock, A. Thromb. Haemost. (2006) [Pubmed]
  3. No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor. Wåhlander, K., Eriksson-Lepkowska, M., Frison, L., Fager, G., Eriksson, U.G. Clin. Pharmacokinet (2003) [Pubmed]
  4. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Wåhlander, K., Larson, G., Lindahl, T.L., Andersson, C., Frison, L., Gustafsson, D., Bylock, A., Eriksson, B.I. Thromb. Haemost. (2002) [Pubmed]
  5. Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis. Wåhlander, K., Lapidus, L., Olsson, C.G., Thuresson, A., Eriksson, U.G., Larson, G., Eriksson, H. Thromb. Res. (2002) [Pubmed]
WikiGenes - Universities